Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

EUIPO sides with Takeda in trademark appeal

28 November 2018 Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark

Big Pharma

Japanese Takeda to acquire Shire for $62bn

8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

Asia-Pacific

Takeda makes fourth offer to buy Shire

23 April 2018 Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

More on this story

Editor's picks

Editor's picks

More features